{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:24:03Z","timestamp":1778261043527,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.vaccine.2009.08.001","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T08:16:37Z","timestamp":1250756197000},"page":"6217-6225","source":"Crossref","is-referenced-by-count":25,"title":["Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections"],"prefix":"10.1016","volume":"27","author":[{"given":"Danica K.","family":"Hickey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank E.","family":"Aldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth W.","family":"Beagley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.08.001_bib1","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.266.18.2565","article-title":"Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000","author":"Washington","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.08.001_bib2","first-page":"375","article-title":"Screening for chlamydial infections in women attending family planning clinics","author":"Schachter","year":"1983","journal-title":"West J Med"},{"key":"10.1016\/j.vaccine.2009.08.001_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00007435-198607000-00010","article-title":"Asymptomatic Chlamydia trachomatis urethritis in men","author":"Stamm","year":"1986","journal-title":"Sex Transm Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.08.001_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2003.10.007","article-title":"Role of atypical bacterial infection of the lung in predisposition\/protection of asthma","volume":"101","author":"Hansbro","year":"2004","journal-title":"Pharmacol Ther"},{"issue":"June","key":"10.1016\/j.vaccine.2009.08.001_bib5","article-title":"Neonatal chlamydial infection induces mixed T cell responses that drive allergic airways disease","author":"Horvat","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.001_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrmicro796","article-title":"Chlamydia pneumoniae\u2014an infectious risk factor for atherosclerosis?","volume":"2","author":"Campbell","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.08.001_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0278-2391(99)90432-9","article-title":"Identification of Chlamydia trachomatis in the human temporomandibular joint","volume":"57","author":"Henry","year":"1999","journal-title":"J Oral Maxillofac Surg"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2009.08.001_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s004300050071","article-title":"Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain","volume":"187","author":"Balin","year":"1998","journal-title":"Med Microbiol Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.08.001_bib9","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/315372","article-title":"Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure","volume":"181","author":"Somani","year":"2000","journal-title":"J Infect Dis"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2009.08.001_bib10","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J Infect Dis"},{"issue":"January (6)","key":"10.1016\/j.vaccine.2009.08.001_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/clinids\/7.6.717","article-title":"Importance of reinfection in the pathogenesis of trachoma","volume":"7","author":"Grayston","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.001_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/IAI.35.3.1024-1031.1982","article-title":"Antigenic analysis of the major outer membrane protein of Chlamydia spp","author":"Caldwell","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.001_bib13","first-page":"218","article-title":"Chlamydia trachomatis antigens: role in immunity and pathogenesis","author":"Brunham","year":"1994","journal-title":"Infect Agent Dis"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2009.08.001_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2249.2007.03357.x","article-title":"Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis","volume":"148","author":"Agrawal","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2009.08.001_bib15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.vaccine.2007.12.048","article-title":"In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB","volume":"26","author":"Barker","year":"2008","journal-title":"Vaccine"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2009.08.001_bib16","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0508983103","article-title":"Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen","volume":"103","author":"Crane","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2009.08.001_bib17","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.vaccine.2006.12.019","article-title":"Expression library immunization confers partial protection against Chlamydia muridarum genital infection","volume":"25","author":"McNeilly","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.001_bib18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2009.08.001_bib19","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2009.08.001_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"June (9629)","key":"10.1016\/j.vaccine.2009.08.001_bib21","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(08)60839-9","article-title":"Use of a patch containing heat-labile toxin from Escherichia coli against travellers\u2019 diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial","volume":"371","author":"Frech","year":"2008","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.08.001_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/IAI.71.1.101-108.2003","article-title":"Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice","volume":"71","author":"Aldwell","year":"2003","journal-title":"Infect Immun"},{"issue":"May (27)","key":"10.1016\/j.vaccine.2009.08.001_bib23","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.vaccine.2005.01.150","article-title":"Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis","volume":"23","author":"Buddle","year":"2005","journal-title":"Vaccine"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2009.08.001_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0264-410X(03)00539-5","article-title":"Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums","volume":"22","author":"Aldwell","year":"2003","journal-title":"Vaccine"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2009.08.001_bib25","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.vaccine.2005.11.017","article-title":"Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis","volume":"24","author":"Aldwell","year":"2006","journal-title":"Vaccine"},{"issue":"6670","key":"10.1016\/j.vaccine.2009.08.001_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/36014","article-title":"Skin immunization made possible by cholera toxin [letter]","volume":"391","author":"Glenn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.08.001_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu Rev Immunol"},{"issue":"March (6673)","key":"10.1016\/j.vaccine.2009.08.001_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.08.001_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/IAI.72.2.1019-1028.2004","article-title":"Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection","volume":"72","author":"Berry","year":"2004","journal-title":"Infect Immun"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2009.08.001_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2005.07.104","article-title":"Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection","volume":"24","author":"Skelding","year":"2006","journal-title":"Vaccine"},{"issue":"June (9)","key":"10.1016\/j.vaccine.2009.08.001_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0161-5890(00)00074-2","article-title":"Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract","volume":"37","author":"Gockel","year":"2000","journal-title":"Mol Immunol"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2009.08.001_bib32","doi-asserted-by":"crossref","first-page":"11143","DOI":"10.1073\/pnas.93.20.11143","article-title":"A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells","volume":"93","author":"Su","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"October (31\u201332)","key":"10.1016\/j.vaccine.2009.08.001_bib33","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.vaccine.2004.04.021","article-title":"Intranasal immunization with C. muridarum major outer membrane protein (MOMP) and cholera toxin elicits local production of neutralising IgA in the prostate","volume":"22","author":"Hickey","year":"2004","journal-title":"Vaccine"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2009.08.001_bib34","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.156.11.4338","article-title":"Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection","volume":"156","author":"Yang","year":"1996","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.001_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1381612033392486","article-title":"Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology","volume":"9","author":"Yang","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.vaccine.2009.08.001_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1365-2567.1997.00378.x","article-title":"B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis","author":"Johansson","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2009.08.001_bib37","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1128\/IAI.69.4.2643-2649.2001","article-title":"Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells","author":"Morrison","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.001_bib38","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection","author":"Morrison","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.001_bib39","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1128\/IAI.68.12.6979-6987.2000","article-title":"Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells","author":"Morrison","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.001_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/IAI.38.2.745-754.1982","article-title":"Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein","author":"Caldwell","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.001_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0264-410X(97)00206-5","article-title":"Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge","author":"Pal","year":"1997","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.08.001_bib42","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1172\/JCI27821","article-title":"Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria","volume":"116","author":"Yoshida","year":"2006","journal-title":"J Clin Invest"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2009.08.001_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00281-006-0054-z","article-title":"IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity","volume":"28","author":"Yoshida","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2009.08.001_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0897.1994.tb00845.x","article-title":"Secretory immunity in the female reproductive tract","author":"Kutteh","year":"1994","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2009.08.001_bib45","first-page":"56","article-title":"Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component-containing cells","author":"Kutteh","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2009.08.001_bib46","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1083\/jcb.141.4.905","article-title":"Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains","author":"Orlandi","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2009.08.001_bib47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1083\/jcb.141.4.917","article-title":"Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia","author":"Wolf","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2009.08.001_bib48","doi-asserted-by":"crossref","first-page":"16249","DOI":"10.1074\/jbc.M109834200","article-title":"Uncoupling of the cholera toxin-G(M1) ganglioside receptor complex from endocytosis, retrograde Golgi trafficking, and downstream signal transduction by depletion of membrane cholesterol","author":"Wolf","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.08.001_bib49","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E03-06-0354","article-title":"Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm","author":"Fujinaga","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.vaccine.2009.08.001_bib50","doi-asserted-by":"crossref","DOI":"10.4161\/auto.1.1.1589","article-title":"Macrophages rapidly transfer pathogens from lipid raft vacuoles to autophagosomes","author":"Amer","year":"2005","journal-title":"Autophagy"},{"key":"10.1016\/j.vaccine.2009.08.001_bib51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ni1028","article-title":"TLR9 signals after translocating from the ER to CpG DNA in the lysosome","author":"Latz","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2009.08.001_bib52","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0021-9258(19)86027-1","article-title":"Lipid domains in membranes. Evidence derived from structural perturbations induced by free fatty acids and lifetime heterogeneity analysis","author":"Klausner","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.08.001_bib53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.biophys.32.110601.141803","article-title":"Model systems, lipid rafts, and cell membranes","author":"Simons","year":"2004","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.vaccine.2009.08.001_bib54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.immunol.21.120601.141021","article-title":"Location is everything: lipid rafts and immune cell signalling","author":"Dykstra","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2009.08.001_bib55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1083\/jcb.143.3.637","article-title":"Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains","volume":"143","author":"Stulnig","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2009.08.001_bib56","doi-asserted-by":"crossref","first-page":"37335","DOI":"10.1074\/jbc.M106193200","article-title":"Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition","author":"Stulnig","year":"2001","journal-title":"J Biol Chem"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2009.08.001_bib57","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.174.9.5390","article-title":"Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4","volume":"174","author":"Weatherill","year":"2005","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09011645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09011645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T11:40:53Z","timestamp":1685101253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09011645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":57,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0264410X09011645"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}